FDA Finalizes Voluntary Improvement Program Guidance Document

The US FDA has finalized a guidance document on the Voluntary Improvement Program, which aims to help manufacturers continuously improve quality and compliance.

Businessman holding card that says "VIP Member."
• Source: Shutterstock

The US Food and Drug Administration has finalized a guidance document on the Voluntary Improvement Program (VIP), an agency initiative that encourages manufacturers to work with third parties to improve device quality and performance.

The program is an offshoot of the Case for Quality and Case for Quality Pilot, earlier Center for Devices and Radiological Health (CDRH) projects that explored the best strategies to guide device makers to continuous quality improvement

More from Regulation

More from Policy & Regulation